NDC 65086-001

Verkazia

Cyclosporine

Verkazia is a Ophthalmic; Topical Emulsion in the Human Prescription Drug category. It is labeled and distributed by Santen Incorporated. The primary component is Cyclosporine.

Product ID65086-001_c795cd2f-89db-78e3-e053-2a95a90a9422
NDC65086-001
Product TypeHuman Prescription Drug
Proprietary NameVerkazia
Generic NameCyclosporine
Dosage FormEmulsion
Route of AdministrationOPHTHALMIC; TOPICAL
Marketing Start Date2022-02-01
Marketing CategoryNDA /
Application NumberNDA214965
Labeler NameSanten Incorporated
Substance NameCYCLOSPORINE
Active Ingredient Strength1 mg/mL
Pharm ClassesCalcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 65086-001-05

1 POUCH in 1 CARTON (65086-001-05) > 5 VIAL, SINGLE-DOSE in 1 POUCH > .3 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-02-01
NDC Exclude FlagN
Sample Package?Y

Drug Details

NDC Crossover Matching brand name "Verkazia" or generic name "Cyclosporine"

NDCBrand NameGeneric Name
0074-3108GengrafCyclosporine
0074-3109GengrafCyclosporine
0074-7269GengrafCyclosporine
0078-0246Neoralcyclosporine
0078-0248Neoralcyclosporine
0023-9163RESTASIScyclosporine
0023-5301Restasis MultiDosecyclosporine
0078-0109Sandimmunecyclosporine
0078-0110Sandimmunecyclosporine
0078-0240Sandimmunecyclosporine
0078-0241Sandimmunecyclosporine

Trademark Results [Verkazia]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VERKAZIA
VERKAZIA
90001921 not registered Live/Pending
Santen S.A.S
2020-06-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.